UW Madison Group Wins NCI Funding for Microfluidic Device to Aid CTC Analysis | GenomeWeb

NEW YORK (GenomeWeb) — A group at the University of Wisconsin, Madison recently received a five-year grant totaling approximately $1.5 million from the National Cancer Institute to develop a microfluidic chip that will combine circulating tumor cell purification, DNA and RNA extraction, and protein analysis.

The integrated platform, the result of a collaboration between biomedical engineers and oncologists at UW-Madison's Wisconsin Institutes for Medical Research, is intended for clinical use, and could generate a "comprehensive snapshot" of CTC function at a molecular level.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.